Skip to main content

Advertisement

SpringerLink
Log in

Treatment Outcomes in Anaplastic Thyroid Carcinoma: Survival Improvement in Young Patients With Localized Disease Treated by Combination of Surgery and Radiotherapy

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Anaplastic thyroid carcinoma (ATC) is a notoriously aggressive malignancy associated with a highly lethal clinical course despite therapeutic intervention. Our present study attempts to identify factors that could potentially improve therapeutic strategies by analyzing the clinicopathological features, treatment and outcome of ATC patients managed over the past four decades at our institution.

Methods

Fifty patients with biopsy-proven ATC during the period 1966 to 2006 were studied. All patients were managed with surgery, radiotherapy, chemotherapy and/or chemoradiation. Survival was calculated by the Kaplan-Meier method. Potential factors affecting survival were compared by the log rank test.

Results

Most patients (88%) presented with a neck mass; 17 patients (34%) also had cervical lymphadenopathy. Distant metastases were clinically present in 9 (18%). Median survival was 97 days, whereas the 1- and 3-year survival was 14% and 8%, respectively. On univariate analysis, patients aged ≤65 years (P = .04), absence of metastatic disease at presentation (P < .01), surgical resection (P < .01), and postoperative radiotherapy (P < .01) were associated with longer survival. The adoption of cytotoxic chemotherapy was not associated with better survival (P = .4). Moreover, there was no improvement in survival rate over the last four decades despite the adoption of multimodal treatment (P = .5).

Conclusion

ATC remains a deadly disease despite technical advances in surgical technique and adoption of multidisciplinary treatment strategies over the last four decades. However, younger patients with localized ATC might benefit from an aggressive multidisciplinary approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hundahl SA, Fleming ID, Fremgen AM et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995. Cancer 1998;83:2638–48

    Article  PubMed  CAS  Google Scholar 

  2. Kitamura Y, Shimizu K, Nagahama M et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 1999;84:4043–9

    Article  PubMed  CAS  Google Scholar 

  3. Aldinger KA, Samaan NA, Ibanez M et al. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer 1978;41:2267–75

    Article  PubMed  CAS  Google Scholar 

  4. Demeter JG, De Jong SA, Lawrence AM et al. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 1991;110:956–61

    PubMed  CAS  Google Scholar 

  5. Schlumberger M, Parmentier C, Delisle MJ et al. Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer 1991;67:564–6

    Article  PubMed  CAS  Google Scholar 

  6. Kobayashi T, Asakawa H, Umeshita K et al. Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck 1996;18:36–41

    Article  PubMed  CAS  Google Scholar 

  7. Rosen IB. (1997) Anaplastic carcinoma of the thyroid gland. In Duh QY, Clark OH (eds). Textbook of Endocrine Surgery. Philadelphia: Sauders. 127–32

  8. Goldman JM, Goren EN, Cohen MH et al. Anaplastic thyroid carcinoma: long-term survival after radical surgery. J Surg Oncol 1980;14:389–94

    Article  PubMed  CAS  Google Scholar 

  9. Mitchell G, Huddart R, Harmer C. Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol 1999;50:33–8

    Article  PubMed  CAS  Google Scholar 

  10. Simpson WJ. Anaplastic thyroid carcinoma: a new approach. Can J Surg 1980;23:25–7

    PubMed  CAS  Google Scholar 

  11. Kim JH, Leeper RD. Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination Adriamycin and radiation therapy. A new approach. Cancer 1983;52:954–7

    Article  PubMed  CAS  Google Scholar 

  12. Tennvall J, Tallroth E, el Hassan A et al. Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery. Acta Oncol 1990;29:1025–8

    Article  PubMed  CAS  Google Scholar 

  13. Voutilainen PE, Multanen M, Haapiainen RK et al. Anaplastic thyroid carcinoma survival. World J Surg 1999;23:975–8

    Article  PubMed  CAS  Google Scholar 

  14. Kebebew E, Greenspan FS, Clark OH et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 2005;103:1330–5

    Article  PubMed  Google Scholar 

  15. Lo CY, Lam KY, Wan KY. Anaplastic carcinoma of the thyroid. Am J Surg 1999;177:337–9

    Article  PubMed  CAS  Google Scholar 

  16. Lang BH, Lo CY. Surgical options in undifferentiated thyroid carcinoma. World J Surg 2007;31:969–77

    Article  PubMed  Google Scholar 

  17. Myskow MW, Krajewski AS, Dewar AE et al. The role of immunoperoxidase techniques on paraffin embedded tissue in determining the histogenesis of undifferentiated thyroid neoplasms. Clin Endocrinol (Oxf) 1986;24:335–41

    Article  CAS  Google Scholar 

  18. Tobler A, Maurer R, Hedinger CE. Undifferentiated thyroid tumors of diffuse small cell type. Histological and immunohistochemical evidence for their lymphomatous nature. Virchows Arch A Pathol Anat Histopathol 1984;404:117–26

    Article  PubMed  CAS  Google Scholar 

  19. Haigh PI, Ituarte PH, Wu HS et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001;91:2335–42

    Article  PubMed  CAS  Google Scholar 

  20. Tan RK, Finley RK 3rd, Driscoll D et al. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 1995;17:41–7

    Article  PubMed  CAS  Google Scholar 

  21. Hadar T, Mor C, Shvero J et al. Anaplastic carcinoma of the thyroid. Eur J Surg Oncol 1993;19:511–6

    PubMed  CAS  Google Scholar 

  22. Ain KB. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 1998;8:715–26

    Article  PubMed  CAS  Google Scholar 

  23. Venkatesh YS, Ordonez NG, Schultz PN et al. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 1990;66:321–30

    Article  PubMed  CAS  Google Scholar 

  24. Sugitani I, Kasai N, Fujimoto Y et al. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 2001;25:617–22

    Article  PubMed  CAS  Google Scholar 

  25. Sugino K, Ito K, Mimura T et al. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 2002;131:245–8

    Article  PubMed  Google Scholar 

  26. Pierie JP, Muzikansky A, Gaz RD et al. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 2002;9:57–64

    Article  PubMed  Google Scholar 

  27. Shimaoka K, Schoenfeld DA, DeWys WD et al. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 1985;56:2155–60

    Article  PubMed  CAS  Google Scholar 

  28. Asakawa H, Kobayashi T, Komoike Y et al. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma. Anticancer Res 1997;17:2757–62

    PubMed  CAS  Google Scholar 

  29. Williams SD, Birch R, Einhorn LH. Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial. Cancer Treat Rep 1986;70:405–7

    PubMed  CAS  Google Scholar 

  30. Ain KB, Egorin MJ, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 2000;10:587–94

    Article  PubMed  CAS  Google Scholar 

  31. Schiff BA, McMurphy AB, Jasser SA et al. Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res 2004;10:8594–602

    Article  PubMed  CAS  Google Scholar 

  32. Straight AM, Oakley K, Moores R et al. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes. Cancer Chemother Pharmacol 2006;57:7–14

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Hong Kong Medical Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China

    Thomas Yau MBBS & R. J. Epstein MD

  2. Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China

    C. Y. Lo MS & Brian H. Lang MS

  3. Department of Pathology, University of Hong Kong Medical Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China

    A. K. Y. Lam MD, PhD

  4. Department of Clinical Oncology, University of Hong Kong Medical Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China

    K. Y. Wan MBBS

Authors
  1. Thomas Yau MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Y. Lo MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. J. Epstein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. K. Y. Lam MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Y. Wan MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Brian H. Lang MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Y. Lo MS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yau, T., Lo, C.Y., Epstein, R.J. et al. Treatment Outcomes in Anaplastic Thyroid Carcinoma: Survival Improvement in Young Patients With Localized Disease Treated by Combination of Surgery and Radiotherapy. Ann Surg Oncol 15, 2500–2505 (2008). https://doi.org/10.1245/s10434-008-0005-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0005-0

Keywords

Search

Navigation